Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Doretti

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of Neurology|May 5, 2023
Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patientsEdoardo Nicolò Aiello, Federica Solca, Lucia Catherine Greco, et al.
Annals of Clinical and Translational Neurology|April 25, 2025
KIF5A p.Pro986Leu Risk Variant and Accelerated Progression of Amyotrophic Lateral SclerosisArianna Manini, Rosario Vasta, Alberto Brusati, et al.
BMC Neurology|November 4, 2024
Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patientsEdoardo Nicolò Aiello, Federica Solca, Silvia Torre, et al.
Frontiers in Psychology|February 6, 2023
Standardization of the Italian ALS-CBS™ Caregiver Behavioral QuestionnaireEdoardo Nicolò Aiello, Federica Solca, Lucia Catherine Greco, et al.
Neurology and Therapy|June 20, 2026
ECAS-Based Neuropsychological Phenotyping in Amyotrophic Lateral Sclerosis: A Retrospective Study Comparing Different AlgorithmsBarbara Poletti, Edoardo N Aiello, Monica Consonni, et al.
Journal of Neurology|August 22, 2025
Whole genome sequencing analysis in primary lateral sclerosis (PLS) patients reveals mutations in neurological diseases-causing genesArianna Manini, Alberto Brusati, Maurizio Grassano, et al.
Brain Communications|September 18, 2024
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trialGiulia Gianferrari, Riccardo Cuoghi Costantini, Valeria Crippa, et al.
Molecular Neurodegeneration|May 15, 2025
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosisAdam N Trautwig, Edward J Fox, Eric B Dammer, et al.
Annals of Neurology|June 25, 2025
Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral SclerosisFederico Ranieri, Gianmaria Senerchia, Luigi Bonan, et al.
Neurology and Therapy|March 7, 2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 StudyPiero Barbanti, Gabriella Egeo, Stefania Proietti, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Neurology|May 5, 2023
Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patientsEdoardo Nicolò Aiello, Federica Solca, Lucia Catherine Greco, et al.
Annals of Clinical and Translational Neurology|April 25, 2025
KIF5A p.Pro986Leu Risk Variant and Accelerated Progression of Amyotrophic Lateral SclerosisArianna Manini, Rosario Vasta, Alberto Brusati, et al.
BMC Neurology|November 4, 2024
Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patientsEdoardo Nicolò Aiello, Federica Solca, Silvia Torre, et al.
Frontiers in Psychology|February 6, 2023
Standardization of the Italian ALS-CBS™ Caregiver Behavioral QuestionnaireEdoardo Nicolò Aiello, Federica Solca, Lucia Catherine Greco, et al.
Neurology and Therapy|June 20, 2026
ECAS-Based Neuropsychological Phenotyping in Amyotrophic Lateral Sclerosis: A Retrospective Study Comparing Different AlgorithmsBarbara Poletti, Edoardo N Aiello, Monica Consonni, et al.
Journal of Neurology|August 22, 2025
Whole genome sequencing analysis in primary lateral sclerosis (PLS) patients reveals mutations in neurological diseases-causing genesArianna Manini, Alberto Brusati, Maurizio Grassano, et al.
Brain Communications|September 18, 2024
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trialGiulia Gianferrari, Riccardo Cuoghi Costantini, Valeria Crippa, et al.
Molecular Neurodegeneration|May 15, 2025
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosisAdam N Trautwig, Edward J Fox, Eric B Dammer, et al.
Annals of Neurology|June 25, 2025
Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral SclerosisFederico Ranieri, Gianmaria Senerchia, Luigi Bonan, et al.
Neurology and Therapy|March 7, 2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 StudyPiero Barbanti, Gabriella Egeo, Stefania Proietti, et al.
Pageof 7